BioCentury | Oct 11, 2014
Company News

Management tracks

...banking group. He was previously the head of the healthcare and investment banking team at Merriman Curhan Ford...
BioCentury | Mar 15, 2010
Analyst Picks & Changes

Analyst picks & changes

...with $221M in cash, has a "healthy cash position" (see B7). Facet Biotech Corp. (NASDAQ:FACT) Merriman Curhan Ford...
BioCentury | Mar 8, 2010
Financial News

Anthera completes IPO

...6 million Price: $7 Shares after offering: 21.6 million Underwriters: Deutsche Bank; Piper Jaffray; Cowen; Merriman Curhan Ford...
BioCentury | Mar 8, 2010
Finance

Ebb & flow

...million and been valued at $242.2 million. Underwriters were Deutsche Bank; Piper Jaffray; Cowen; and Merriman Curhan Ford...
BioCentury | Mar 2, 2010
Financial News

Anthera raises $42M in IPO

...million shares at $7 in an IPO underwritten by Deutsche Bank; Piper Jaffray; Cowen; and Merriman Curhan Ford...
BioCentury | Mar 1, 2010
Financial News

Anthera amends IPO

...6 million Price: $7 Shares after offering: 21.6 million Underwriters: Deutsche Bank; Piper Jaffray; Cowen; Merriman Curhan Ford...
BioCentury | Mar 1, 2010
Analyst Picks & Changes

Analyst picks & changes

...& changes Company Bank Analyst Coverage Opinion Wk chg 2/26 cls Acorda Therapeutics Inc. (NASDAQ:ACOR) Merriman Curhan Ford...
BioCentury | Mar 1, 2010
Finance

No deal for Anthera

...Co. (NYSE:LLY) and Shionogi & Co. Ltd. Underwriters are Deutsche Bank; Piper Jaffray; Cowen; and Merriman Curhan Ford...
BioCentury | Feb 27, 2010
Financial News

Anthera amends IPO

...filed in September to raise up to $70 million. Deutsche Bank; Piper Jaffray; Cowen; and Merriman Curhan Ford...
BioCentury | Feb 22, 2010
Analyst Picks & Changes

Analyst Picks & Changes

...his peak U.S. sales estimate of over $600M for Dupuytren's contracture alone. Depomed Inc. (NASDAQ:DEPO) Merriman Curhan Ford...
Items per page:
1 - 10 of 149
BioCentury | Oct 11, 2014
Company News

Management tracks

...banking group. He was previously the head of the healthcare and investment banking team at Merriman Curhan Ford...
BioCentury | Mar 15, 2010
Analyst Picks & Changes

Analyst picks & changes

...with $221M in cash, has a "healthy cash position" (see B7). Facet Biotech Corp. (NASDAQ:FACT) Merriman Curhan Ford...
BioCentury | Mar 8, 2010
Financial News

Anthera completes IPO

...6 million Price: $7 Shares after offering: 21.6 million Underwriters: Deutsche Bank; Piper Jaffray; Cowen; Merriman Curhan Ford...
BioCentury | Mar 8, 2010
Finance

Ebb & flow

...million and been valued at $242.2 million. Underwriters were Deutsche Bank; Piper Jaffray; Cowen; and Merriman Curhan Ford...
BioCentury | Mar 2, 2010
Financial News

Anthera raises $42M in IPO

...million shares at $7 in an IPO underwritten by Deutsche Bank; Piper Jaffray; Cowen; and Merriman Curhan Ford...
BioCentury | Mar 1, 2010
Financial News

Anthera amends IPO

...6 million Price: $7 Shares after offering: 21.6 million Underwriters: Deutsche Bank; Piper Jaffray; Cowen; Merriman Curhan Ford...
BioCentury | Mar 1, 2010
Analyst Picks & Changes

Analyst picks & changes

...& changes Company Bank Analyst Coverage Opinion Wk chg 2/26 cls Acorda Therapeutics Inc. (NASDAQ:ACOR) Merriman Curhan Ford...
BioCentury | Mar 1, 2010
Finance

No deal for Anthera

...Co. (NYSE:LLY) and Shionogi & Co. Ltd. Underwriters are Deutsche Bank; Piper Jaffray; Cowen; and Merriman Curhan Ford...
BioCentury | Feb 27, 2010
Financial News

Anthera amends IPO

...filed in September to raise up to $70 million. Deutsche Bank; Piper Jaffray; Cowen; and Merriman Curhan Ford...
BioCentury | Feb 22, 2010
Analyst Picks & Changes

Analyst Picks & Changes

...his peak U.S. sales estimate of over $600M for Dupuytren's contracture alone. Depomed Inc. (NASDAQ:DEPO) Merriman Curhan Ford...
Items per page:
1 - 10 of 149